Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lučka Boltežar

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Zdravstveno Varstvo|September 27, 2016
Voice Disorders in Occupations with Vocal Load in SloveniaLučka Boltežar, Maja Šereg Bahar
Therapeutics and Clinical Risk Management|March 10, 2021
Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell LymphomaBarbara Jezeršek Novaković, Lučka Boltežar, Aleksander Novaković
Journal of Assisted Reproduction and Genetics|December 19, 2015
Fertility in young patients following treatment for Hodgkin's lymphoma: a single center surveyLučka Boltežar, Karlo Pintarić, Barbara Jezeršek Novaković
Hereditary Cancer in Clinical Practice|March 25, 2020
An interesting case of likely <i>BRCA2</i> related bilateral breast cancer with metastasis in the fimbrial part of fallopian tubeLučka Boltežar, Gorana Gašljević, Srdjan Novaković, et al.
Biomedicines|February 24, 2024
Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology LjubljanaLučka Boltežar, Samo Rožman, Gorana Gašljević, et al.
Oncology Letters|May 8, 2018
Comparison of the algorithms classifying the ABC and GCB subtypes in diffuse large B-cell lymphomaLučka Boltežar, Veronika Kloboves Prevodnik, Maja Pohar Perme, et al.
Cancers|December 17, 2024
FoxP3<sup>+</sup> Regulatory T-Cell Quantities in Nodal T-Follicular Helper Cell Lymphomas and Peripheral T-Cell Lymphomas Not Otherwise Specified and Their Impact on Overall SurvivalEva Erzar, Alexandar Tzankov, Janja Ocvirk, et al.
Oncology Letters|February 23, 2018
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisoloneMatej Horvat, Vesna Zadnik, Tanja Južnič Šetina, et al.
Annals of Hematology|November 12, 2025
Insights into Nodal T-Follicular Helper Cell lymphomas and Peripheral T-Cell Lymphomas, Not Otherwise Specified, in Slovenian Patients: Mutational Landscape, Clinicopathological Characteristics, and OutcomesEva Erzar, Vanesa Sindi-Ivanova, Stefan Dirnhofer, et al.
BMC Infectious Diseases|July 22, 2025
Respiratory microbiome alterations, coinfections and virus intra-host evolution in a persistently active SARS-CoV-2 infectionLučka Boltežar, Rok Kogoj, Katarina Resman Rus, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Zdravstveno Varstvo|September 27, 2016
Voice Disorders in Occupations with Vocal Load in SloveniaLučka Boltežar, Maja Šereg Bahar
Therapeutics and Clinical Risk Management|March 10, 2021
Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell LymphomaBarbara Jezeršek Novaković, Lučka Boltežar, Aleksander Novaković
Journal of Assisted Reproduction and Genetics|December 19, 2015
Fertility in young patients following treatment for Hodgkin's lymphoma: a single center surveyLučka Boltežar, Karlo Pintarić, Barbara Jezeršek Novaković
Hereditary Cancer in Clinical Practice|March 25, 2020
An interesting case of likely <i>BRCA2</i> related bilateral breast cancer with metastasis in the fimbrial part of fallopian tubeLučka Boltežar, Gorana Gašljević, Srdjan Novaković, et al.
Biomedicines|February 24, 2024
Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology LjubljanaLučka Boltežar, Samo Rožman, Gorana Gašljević, et al.
Oncology Letters|May 8, 2018
Comparison of the algorithms classifying the ABC and GCB subtypes in diffuse large B-cell lymphomaLučka Boltežar, Veronika Kloboves Prevodnik, Maja Pohar Perme, et al.
Cancers|December 17, 2024
FoxP3<sup>+</sup> Regulatory T-Cell Quantities in Nodal T-Follicular Helper Cell Lymphomas and Peripheral T-Cell Lymphomas Not Otherwise Specified and Their Impact on Overall SurvivalEva Erzar, Alexandar Tzankov, Janja Ocvirk, et al.
Oncology Letters|February 23, 2018
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisoloneMatej Horvat, Vesna Zadnik, Tanja Južnič Šetina, et al.
Annals of Hematology|November 12, 2025
Insights into Nodal T-Follicular Helper Cell lymphomas and Peripheral T-Cell Lymphomas, Not Otherwise Specified, in Slovenian Patients: Mutational Landscape, Clinicopathological Characteristics, and OutcomesEva Erzar, Vanesa Sindi-Ivanova, Stefan Dirnhofer, et al.
BMC Infectious Diseases|July 22, 2025
Respiratory microbiome alterations, coinfections and virus intra-host evolution in a persistently active SARS-CoV-2 infectionLučka Boltežar, Rok Kogoj, Katarina Resman Rus, et al.
Pageof 1